Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

OMACOR SOFT CAPSULE 1000MG [SIN14504P]

Active ingredients: OMEGA-3-ACID ETHYL ESTERS 90 (CONTAINING: EICOSAPENT (EPA) 460 MG AND DOCONEXENT (DHA) 380 MG ETHYL ESTERS AND α-TOCOPHEROL 4 MG)

View product's general information
Last updated on 9 October 2026

Product Info

OMACOR SOFT CAPSULE 1000MG

[SIN14504P]

Product information

Active Ingredient and Strength

OMEGA-3-ACID ETHYL ESTERS 90 (CONTAINING: EICOSAPENT (EPA) 460 MG AND DOCONEXENT (DHA) 380 MG ETHYL ESTERS AND α-TOCOPHEROL 4 MG) - 1,000 MG

Dosage Form

CAPSULE

Manufacturer and Country

PATHEON SOFTGELS B.V. - NETHERLANDS
TROMMSDORFF GMBH & CO. KG (PRIMARY PACKAGER) - GERMANY

Registration Number

SIN14504P

Licence Holder

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

C10AX06

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

4.1 Therapeutic indications
Hypertriglyceridaemia
Endogenous hypertriglyceridaemia: as a supplement to diet when dietary measures alone are insufficient to produce an adequate response.

  • type IV in monotherapy,

  • type IIb in combination with statins, when control of triglycerides is insufficient.

Omacor is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). There is only limited experience in secondary endogenous hypertriglyceridaemia (especially uncontrolled diabetes).

Dosing

4.2 Posology and method of administration
Hypertriglyceridaemia
The daily dose is 4 grams per day taken as a single 4-gram dose (4 capsules) or as two 2-gram doses (2 capsules given twice daily).

The capsules should be taken with food to avoid gastrointestinal disturbances.
There is limited clinical data regarding the use of Omacor in elderly patients over 70 years of age and patients with renal impairment (see section 4.4 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information). There is no information regarding the use of Omacor in children and adolescents or in patients with hepatic impairment (see section 4.4 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

Contraindications

4.3 Contraindications
Hypersensitivity to the active substance, to soya or to any of the excipients listed in section 6.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.

Omacor contains soya oil. If you are allergic to peanut or soya, do not use this medicinal product.